Table 1.
Complete Response | No Complete Response | ||||
---|---|---|---|---|---|
Characteristic | No. of Patients | % | No. of Patients | % | P |
No. of Patients | 47 | 41 | |||
Gender | |||||
Male | 35 | 74 | 24 | 59 | .17 |
Female | 12 | 26 | 17 | 41 | |
Race | |||||
Caucasian | 40 | 85 | 37 | 90 | |
African American | 4 | 9 | 3 | 7 | .53a |
Asian | 2 | 4 | 0 | 0 | |
Other | 1 | 2 | 1 | 2 | |
Age | |||||
Median (years) | 13.2 | 14.0 | .97 | ||
Range (years) | 4.7–20.6 | 4.4–19.1 | |||
Histology | |||||
Nodular sclerosing | 11 | 23 | 26 | 63 | <.001b |
Mixed cellularity | 5 | 11 | 5 | 12 | |
Lymphocyte rich | 2 | 4 | 1 | 2 | |
Classical, not otherwise specified | 3 | 6 | 3 | 7 | |
Nodular Lymphocyte predominant | 26 | 55 | 6 | 15 | <.001c |
Stage | |||||
IA | 27 | 57 | 12 | 29 | .010 |
IIA | 20 | 43 | 29 | 71 | |
Mediastinal mass | |||||
Absent | 36 | 77 | 17 | 41 | .001 |
Present | 11 | 23 | 24 | 59 | |
Bulkd | |||||
Absent | 43 | 91 | 32 | 78 | .13 |
Present | 4 | 9 | 9 | 22 |
Comparison of Caucasian vs. other races
Comparison of nodular sclerosing vs. other histologies
Comparison of lymphocyte predominant vs. other histologies
Peripheral lymph node disease ≥ 6 cm